Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bult

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|September 18, 2009
In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-upP Bult, P Manders, H M P M Straatman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limitedN Hoogerbrugge, Y J L Kamm, P Bult, et al.
Breast Cancer Research : BCR|October 19, 2019
Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancerD J P van Uden, M C van Maaren, L J A Strobbe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2013
Models predicting non-sentinel node involvement also predict for regional recurrence in breast cancer patients without axillary treatmentM J A E Pepels, J H M J Vestjens, M de Boer, et al.
Surgical Oncology|June 21, 2020
Better survival after surgery of the primary tumor in stage IV inflammatory breast cancerD J P van Uden, M C van Maaren, L J A Strobbe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2013
Is the sentinel lymph node pathology protocol in breast cancer patients associated with the risk of regional recurrence?M J Bolster, M J Pepels, C A P Wauters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2005
Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancerW Kievit, M J Bolster, G J van der Wilt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2012
Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastasesM de Boer, E M M Adang, K C G Van Dycke, et al.
Breast Cancer Research and Treatment|October 5, 2017
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter studyO Kaidar-Person, I Meattini, P Jain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2012
Relevant impact of central pathology review on nodal classification in individual breast cancer patientsJ H M J Vestjens, M J Pepels, M de Boer, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|September 18, 2009
In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-upP Bult, P Manders, H M P M Straatman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limitedN Hoogerbrugge, Y J L Kamm, P Bult, et al.
Breast Cancer Research : BCR|October 19, 2019
Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancerD J P van Uden, M C van Maaren, L J A Strobbe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2013
Models predicting non-sentinel node involvement also predict for regional recurrence in breast cancer patients without axillary treatmentM J A E Pepels, J H M J Vestjens, M de Boer, et al.
Surgical Oncology|June 21, 2020
Better survival after surgery of the primary tumor in stage IV inflammatory breast cancerD J P van Uden, M C van Maaren, L J A Strobbe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2013
Is the sentinel lymph node pathology protocol in breast cancer patients associated with the risk of regional recurrence?M J Bolster, M J Pepels, C A P Wauters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2005
Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancerW Kievit, M J Bolster, G J van der Wilt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2012
Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastasesM de Boer, E M M Adang, K C G Van Dycke, et al.
Breast Cancer Research and Treatment|October 5, 2017
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter studyO Kaidar-Person, I Meattini, P Jain, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2012
Relevant impact of central pathology review on nodal classification in individual breast cancer patientsJ H M J Vestjens, M J Pepels, M de Boer, et al.
Pageof 5